Pharmacology studies and animal model development and related services for drug development
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95024D00028
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $1,000 obligated
Award facts
- Opportunity
-
- Pharmacology Studies and Animal Model Development and Related Services for Drug Development Pre-Solicitation · 75N95023R00004 · Posted Nov 7, 2022
- Combined order value
- $1,000 Current and potential, with all options
- Last date to order 37% complete
- IDV ceiling <1% used
- $48,882,666.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Advanced Bioscience Laboratories, Inc. with a ceiling of $48.9 million on August 6, 2024, for pharmacology studies and animal model development and related services for drug development.
The contract is not set-aside. Performance occurs in Rockville, Maryland. The period of performance extends through August 5, 2030.
A task order for a kick-off meeting was issued under this contract on August 6, 2024, to the National Center for Advancing Translational Sciences with a firm fixed price of $1,000 and completion by September 30, 2024.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Kick-off meeting for the pharmacology studies and animal model development and related services for drug development… | National Institute on Drug Abuse (NIH) | $1,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00028?
75N95024D00028 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 6, 2024.
How much is contract 75N95024D00028 worth?
Orders under 75N95024D00028 have obligated $1,000. 75N95024D00028's own ceiling is $48,882,666.
How many orders have been placed under contract 75N95024D00028?
1 order has been placed under 75N95024D00028, the latest on August 6, 2024.
Who can order from contract 75N95024D00028?
75N95024D00028 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95024D00028 competed?
The extent of competition for 75N95024D00028 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV